ロード中...
Saxagliptin for type 2 diabetes
Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving glycemic control in patients with type 2 diabetes (T2D). By blocking DPP-4, saxagliptin increases and prolongs the effects of incretins, a group of peptide hormones released by...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047974/ https://ncbi.nlm.nih.gov/pubmed/21437102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSOTT.S12241 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|